Edwards Lifesciences PE Ratio 2010-2024 | EW

Current and historical p/e ratio for Edwards Lifesciences (EW) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Edwards Lifesciences PE ratio as of December 06, 2024 is 26.79.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Edwards Lifesciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-12-05 72.43 10.45
2024-09-30 65.99 $6.93 9.52
2024-06-30 92.37 $2.43 38.01
2024-03-31 95.56 $2.32 41.19
2023-12-31 76.25 $2.30 33.15
2023-09-30 69.28 $2.34 29.61
2023-06-30 94.33 $2.26 41.74
2023-03-31 82.73 $2.29 36.13
2022-12-31 74.61 $2.27 32.87
2022-09-30 82.63 $2.40 34.43
2021-12-31 129.55 $2.39 54.21
2021-09-30 113.21 $2.35 48.17
2021-06-30 103.57 $2.46 42.10
2021-03-31 83.64 $2.20 38.02
2020-12-31 91.23 $1.46 62.49
2022-06-30 95.09 $1.46 65.13
2020-09-30 79.82 $1.25 63.86
2020-06-30 69.11 $1.16 59.41
2020-03-31 62.87 $1.74 36.07
2019-12-31 77.76 $1.65 47.23
2019-09-30 73.30 $1.22 60.25
2019-06-30 61.58 $1.14 54.18
2019-03-31 63.78 $1.20 53.30
2018-12-31 51.06 $1.12 45.45
2018-09-30 58.03 $1.17 49.60
2018-06-30 48.52 $1.08 44.93
2018-03-31 46.51 $0.93 50.19
2017-12-31 37.57 $0.96 39.14
2017-09-30 36.44 $1.15 31.78
2017-06-30 39.41 $1.10 35.83
2017-03-31 31.36 $1.01 31.15
2016-12-31 31.23 $0.87 35.76
2016-09-30 40.19 $0.84 47.65
2016-06-30 33.24 $0.80 41.30
2016-03-31 29.40 $0.78 37.62
2015-12-31 26.33 $1.15 22.86
2015-09-30 23.70 $1.13 21.06
2015-06-30 23.74 $1.11 21.32
2022-03-31 117.72 $1.09 108.16
2015-03-31 23.74 $1.35 17.63
2014-12-31 21.23 $1.25 16.94
2014-09-30 17.03 $1.20 14.19
2014-06-30 14.31 $1.17 12.25
2014-03-31 12.36 $0.46 27.07
2013-12-31 10.96 $0.57 19.23
2013-09-30 11.61 $0.59 19.84
2013-06-30 11.20 $0.57 19.70
2013-03-31 13.69 $0.53 26.00
2012-12-31 15.03 $0.41 36.50
2012-09-30 17.90 $0.37 48.14
2012-06-30 17.22 $0.35 49.66
2012-03-31 12.12 $0.33 36.54
2011-12-31 11.78 $0.33 35.71
2011-09-30 11.88 $0.31 38.52
2011-06-30 14.53 $0.32 45.88
2010-12-31 13.47 $0.30 44.41
2010-09-30 11.18 $0.28 39.90
2010-06-30 9.34 $0.32 29.40
2010-03-31 8.24 $0.31 27.01
2009-12-31 7.24 $0.32 22.32
2009-09-30 5.83 $0.35 16.85
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.188B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.480B 24.70
Intuitive Surgical (ISRG) United States $196.045B 102.50
Alcon (ALC) Switzerland $42.794B 28.63
IQVIA Holdings (IQV) United States $36.777B 20.26
IDEXX Laboratories (IDXX) United States $35.676B 42.01
DexCom (DXCM) United States $30.357B 45.72
Waters (WAT) United States $22.803B 33.72
STERIS (STE) Ireland $21.310B 24.53
SONOVA HOLDING (SONVY) Switzerland $20.157B 0.00
Hologic (HOLX) United States $17.098B 18.47
Fresenius Medical Care AG KGaA (FMS) Germany $14.119B 14.49
Sysmex ADR (SSMXY) Japan $13.255B 0.00
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.105B 89.18
Masimo (MASI) United States $9.091B 43.99
Teleflex (TFX) United States $8.576B 13.68
Glaukos (GKOS) United States $7.735B 0.00
PROCEPT BioRobotics (PRCT) United States $4.949B 0.00
Integer Holdings (ITGR) United States $4.675B 26.50
Veracyte (VCYT) United States $3.420B 102.63
Inari Medical (NARI) United States $2.990B 0.00
LivaNova (LIVN) United Kingdom $2.699B 15.58
Nihon Kohden (NHNKY) Japan $2.361B 17.93
TransMedics (TMDX) United States $2.291B 72.62
Elekta AB (EKTAY) Sweden $2.165B 19.47
Tandem Diabetes Care (TNDM) United States $1.978B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.365B 0.00
Artivion (AORT) United States $1.243B 82.39
Pulse Biosciences (PLSE) United States $1.215B 0.00
OPKO Health (OPK) United States $1.085B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.849B 14.43
Paragon 28 (FNA) United States $0.840B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.712B 0.00
IRadimed (IRMD) United States $0.687B 37.11
Mesa Laboratories (MLAB) United States $0.674B 15.88
AxoGen (AXGN) United States $0.656B 0.00
SiBone (SIBN) United States $0.567B 0.00
OrthoPediatrics (KIDS) United States $0.561B 0.00
Pacific Biosciences Of California (PACB) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.512B 30.12
Treace Medical Concepts (TMCI) United States $0.494B 0.00
Tactile Systems Technology (TCMD) United States $0.439B 23.75
Delcath Systems (DCTH) United States $0.380B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
CVRx (CVRX) United States $0.327B 0.00
AngioDynamics (ANGO) United States $0.284B 0.00
Inogen (INGN) United States $0.226B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.202B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.174B 0.00
Nevro (NVRO) United States $0.157B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.49
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Vicarious Surgical (RBOT) United States $0.095B 0.00
WORK Medical Technology Group (WOK) China $0.092B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
908 Devices (MASS) United States $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00